ARQT
Arcutis BiotherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
ARQT vs peer average
39/100
ARQT vs. peer average (C vs. B)
Grade spread
A 2 · B 5 · C 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
INCY is the first available peer comparator.
Mid-large biotech with inflammation/dermatology programs; useful for commercial and clinical benchmarks.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ARQT
Arcutis Biotherapeutics
INCY
Incyte
Grade
C
B
Momentum
18
46
Value
41
66
Sentiment
97
66
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs INCY
ARQT / INCY
Grade Position
Below peers
ARQT vs. peer average (C vs. B)
39/100
Momentum
18
INCYValue
41
INCYSentiment
97
ARQTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ARQT
INCY is the first peer returned for this comparison set.